FTSE All-Share
5.576,38
PKT
-20,66
PKT
-0,37
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.11.12 | BT Group overweight | J.P. Morgan Cazenove | |
| 02.11.12 | Sky buy | Nomura | |
| 02.11.12 | Imperial Brands underperform | Exane-BNP Paribas SA | |
| 02.11.12 | Aberdeen Group outperform | Exane-BNP Paribas SA | |
| 02.11.12 | BT Group buy | Nomura | |
| 02.11.12 | Lloyds Banking Group reduce | Nomura | |
| 02.11.12 | Imperial Brands kaufen | Independent Research GmbH | |
| 02.11.12 | Unilever buy | UBS AG | |
| 02.11.12 | British Land Company outperform | Exane-BNP Paribas SA | |
| 02.11.12 | Barclays halten | Independent Research GmbH | |
| 02.11.12 | GSK neutral | UBS AG | |
| 02.11.12 | GSK halten | Independent Research GmbH | |
| 02.11.12 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 02.11.12 | Lloyds Banking Group outperform | Exane-BNP Paribas SA | |
| 02.11.12 | Sky outperform | Exane-BNP Paribas SA | |
| 02.11.12 | Sky buy | Deutsche Bank AG | |
| 02.11.12 | Smith Nephew sell | Société Générale Group S.A. (SG) | |
| 02.11.12 | Shell (ex Royal Dutch Shell) hold | Société Générale Group S.A. (SG) | |
| 02.11.12 | Shell (ex Royal Dutch Shell) outperform | Exane-BNP Paribas SA | |
| 02.11.12 | BP neutral | Exane-BNP Paribas SA | |
| 02.11.12 | Shell (ex Royal Dutch Shell) kaufen | National-Bank AG | |
| 02.11.12 | Barclays outperform | Exane-BNP Paribas SA | |
| 02.11.12 | Lloyds Banking Group buy | Société Générale Group S.A. (SG) | |
| 02.11.12 | GSK underperform | Exane-BNP Paribas SA | |
| 02.11.12 | Antofagasta sell | Société Générale Group S.A. (SG) | |
| 02.11.12 | Smith Nephew neutral | Sarasin Research | |
| 02.11.12 | GSK neutral | Credit Suisse Group | |
| 02.11.12 | BAE Systems hold | Société Générale Group S.A. (SG) | |
| 02.11.12 | Lloyds Banking Group neutral | Sarasin Research | |
| 02.11.12 | Barclays overweight | Morgan Stanley | |
| 01.11.12 | HSBC neutral | UBS AG | |
| 01.11.12 | Antofagasta sell | UBS AG | |
| 01.11.12 | GSK neutral | UBS AG | |
| 01.11.12 | Imperial Brands buy | UBS AG | |
| 01.11.12 | Imperial Brands buy | Société Générale Group S.A. (SG) | |
| 01.11.12 | Barclays buy | Société Générale Group S.A. (SG) | |
| 01.11.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 01.11.12 | Next hold | Société Générale Group S.A. (SG) | |
| 01.11.12 | Shell (ex Royal Dutch Shell) buy | Sarasin Research | |
| 01.11.12 | Barclays neutral | Sarasin Research |
